Menu
GeneBe

NDUFS2

NADH:ubiquinone oxidoreductase core subunit S2, the group of NADH:ubiquinone oxidoreductase core subunits

Basic information

Region (hg38): 1:161197103-161214723

Links

ENSG00000158864NCBI:4720OMIM:602985HGNC:7708Uniprot:O75306AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial complex 1 deficiency, nuclear type 6 (Strong), mode of inheritance: AR
  • Leber hereditary optic neuropathy (Supportive), mode of inheritance: Mitochondrial
  • mitochondrial complex I deficiency (Supportive), mode of inheritance: AR
  • Leigh syndrome with cardiomyopathy (Supportive), mode of inheritance: AR
  • Leigh syndrome with leukodystrophy (Supportive), mode of inheritance: AR
  • mitochondrial complex 1 deficiency, nuclear type 6 (Strong), mode of inheritance: AR
  • mitochondrial complex I deficiency, nuclear type 1 (Definitive), mode of inheritance: AR
  • mitochondrial complex 1 deficiency, nuclear type 6 (Limited), mode of inheritance: Unknown
  • Leigh syndrome (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitochondrial complex I deficiency, nuclear type 6; Leber hereditary optic neuropathy, autosomal recessive 2 ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic11743516; 11220739; 20819849; 22036843; 28031252
In Mitochondrial complex I deficiency, nuclear type 5, medical treatment (eg, riboflavin, ubiquinol) may be beneficial, and individuals may have cardiac involvement

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NDUFS2 gene.

  • not provided (161 variants)
  • Mitochondrial complex I deficiency, nuclear type 1 (43 variants)
  • Mitochondrial complex 1 deficiency, nuclear type 6 (34 variants)
  • not specified (33 variants)
  • Inborn genetic diseases (27 variants)
  • Mitochondrial complex I deficiency (9 variants)
  • Leber optic atrophy (1 variants)
  • Leber-like hereditary optic neuropathy, autosomal recessive 2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDUFS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
26
clinvar
1
clinvar
30
missense
1
clinvar
3
clinvar
60
clinvar
3
clinvar
1
clinvar
68
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
2
clinvar
2
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
11
10
21
non coding
23
clinvar
28
clinvar
12
clinvar
63
Total 2 6 89 57 14

Highest pathogenic variant AF is 0.0000132

Variants in NDUFS2

This is a list of pathogenic ClinVar variants found in the NDUFS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-161198003-T-C not specified Uncertain significance (Mar 07, 2024)3077485
1-161198080-C-T not specified Uncertain significance (Nov 09, 2021)2279296
1-161198083-C-T not specified Uncertain significance (Apr 18, 2023)2537579
1-161198101-G-C not specified Uncertain significance (Jun 23, 2023)2598261
1-161198252-T-C not specified Uncertain significance (Aug 16, 2022)2307086
1-161198327-C-T not specified Uncertain significance (Nov 27, 2023)3077466
1-161198330-A-G Likely benign (Dec 01, 2023)3024829
1-161198356-G-A not specified Uncertain significance (Mar 29, 2023)2512660
1-161198377-C-T not specified Uncertain significance (Oct 14, 2021)2353295
1-161198401-C-T not specified Uncertain significance (Mar 01, 2024)3077431
1-161198407-C-T not specified Uncertain significance (Jan 30, 2024)3077421
1-161198423-C-T not specified Uncertain significance (May 09, 2023)2523435
1-161198444-C-T not specified Uncertain significance (Oct 26, 2021)2257408
1-161198585-G-A not specified Likely benign (Jan 12, 2024)3077476
1-161198587-C-T not specified Uncertain significance (Jun 23, 2023)2605864
1-161198603-C-T not specified Likely benign (Oct 27, 2022)2374200
1-161198608-T-C not specified Uncertain significance (May 16, 2022)2299180
1-161199375-G-A Mitochondrial complex I deficiency, nuclear type 1 Uncertain significance (Jan 13, 2018)293261
1-161199375-G-T Mitochondrial complex I deficiency, nuclear type 1 • Mitochondrial complex 1 deficiency, nuclear type 6 Benign (Apr 11, 2023)293262
1-161199417-G-A Mitochondrial complex I deficiency, nuclear type 1 Uncertain significance (Jan 13, 2018)293263
1-161199465-C-G Mitochondrial complex I deficiency, nuclear type 1 Uncertain significance (Jan 12, 2018)293264
1-161201946-A-G Likely benign (Jun 26, 2018)1207148
1-161202163-C-G not specified • Mitochondrial complex I deficiency, nuclear type 1 Conflicting classifications of pathogenicity (Jan 13, 2018)138488
1-161202168-G-A Mitochondrial complex I deficiency, nuclear type 1 Uncertain significance (Jan 13, 2018)293265
1-161202227-C-A Mitochondrial complex I deficiency, nuclear type 1 Uncertain significance (Jan 12, 2018)293266

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NDUFS2protein_codingprotein_codingENST00000367993 1417292
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001420.9991257220261257480.000103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.471922590.7420.00001532994
Missense in Polyphen62122.480.506191343
Synonymous-1.1810893.41.160.00000476919
Loss of Function3.501132.50.3380.00000210320

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002390.000239
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0001420.000139
European (Non-Finnish)0.00007050.0000703
Middle Eastern0.000.00
South Asian0.0002290.000229
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:12611891). {ECO:0000269|PubMed:12611891}.;
Disease
DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]: A disorder of the mitochondrial respiratory chain that causes a wide range of clinical manifestations from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:11220739}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Retrograde endocannabinoid signaling - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Doxorubicin Pathway, Pharmacokinetics;Parkinson,s disease - Homo sapiens (human);Metformin Pathway, Pharmacodynamic;Doxorubicin Metabolism Pathway;Electron Transport Chain;Oxidative phosphorylation;Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;p73 transcription factor network;Complex I biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. (Consensus)

Recessive Scores

pRec
0.419

Intolerance Scores

loftool
0.0524
rvis_EVS
0.49
rvis_percentile_EVS
79.38

Haploinsufficiency Scores

pHI
0.313
hipred
Y
hipred_score
0.642
ghis
0.420

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.981

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ndufs2
Phenotype

Gene ontology

Biological process
mitochondrial electron transport, NADH to ubiquinone;response to oxidative stress;mitochondrial respiratory chain complex I assembly;mitochondrial ATP synthesis coupled electron transport
Cellular component
nucleoplasm;mitochondrion;mitochondrial respiratory chain complex I;mitochondrial matrix
Molecular function
NADH dehydrogenase activity;protein binding;NADH dehydrogenase (ubiquinone) activity;electron transfer activity;ubiquitin protein ligase binding;metal ion binding;quinone binding;NAD binding;4 iron, 4 sulfur cluster binding